Bernard Rentier

Born in 1947, married, 2 children, 4 grand-children, Bernard Rentier is a biologist, specialized in Virology and Immunology. He has made his major contributions on viruses (measles, chicken pox) that infect the nervous system and remain latent, sometimes reactivating later thereby causing severe diseases (subacute sclerosing panencephalitis, zoster).

He authored over 200 publications ( and is or has been a members of numerous associations and learned societies.

He chaired the European branch of the VZV Research Foundation, EuroVar and W.A.V.E.
He founded and chaired two spin-off companies in the Biotech sector (Gamma, acquired by Zentech, and Probiox).
He is now chairing EOS (Enabling Open Scholarship), an association promoting Open Access to scientific publications.

From 1970 to 1976, he worked at the University of Liège (ULg) and at the NIMR, Mill Hill, London, UK.
After obtaining his PhD in Virology in 1976 at ULg, he worked at the NIH, Bethesda MD, USA till 1981 and he obtained a D.Sc in 1982 at ULg.
He became professor in 1989, full Professor in 1997, he was elected Vice-Rector the same year and Rector in 2005.
He will be leaving office on September 30, 2014 and he will hold the presidency of the « Société Libre d’Emulation », a 240 years old respected cultural institution in Liège aiming at promoting Science and Art.

Since 1997, being responsible for Research and Libraries at ULg, he became involved in the crusade against the uncontrollable growth of documentation expenditures and he has been a pioneer in the Open Access (OA) movement.
He urged his University as well as the National Fund for Scientific Research (FNRS) and the Ministry of Higher Education and Research to sign the Berlin Declaration on OA and he has been very active in developing, from 2007 on, a very per formative institutional repository of publication in the « Green OA » mode, supported by a strong OA mandate known nowadays worldwide as « the Liege Model of OA ». As an outspoken advocate of OA, he is frequently invited worldwide to express his views on the new evolution of scholarly communication and of research in general.
He is also very active on social networks.

François Pernot

François PERNOT is French, he was born in Burgundy, and he is graduate of HEC Paris. He started his career in the garment industry in Lyon before staying for a few years in Madagascar. When he returned in Europe, in 1995, he joined Dargaud France as international and marketing manager before being promoted to become the CEO of Dargaud-Lombard in 1997.
Dargaud-Lombard is known for their comic characters such as Thorgal, Yakari, The Smurfs, Blake and Mortimer, XIII, Boule et Bill, … , amongst others and for their KANA Manga series in partnership with Shueisha, Shogakukan and Kadokawa for characters such as Naruto, Death Note, Shaman King, Yu Gi Oh, Conan, Keroro, …
Since 2009, he is also CEO of the Comics and Animation Division of the Media-Participations Group, european leader in comics through their publishing companies (Dargaud, Dupuis, Le Lombard, Urban and Kana) and european mainest producer and distributor of tv animation series with their studios (Ellipsanime, Storimages, Belvision, Dargaud Media, Cartooners) and their dedicated subsidiaries (Mediatoon and Citel).

François Damas

François Damas is born in 1953 and currently works for the La Citadelle Hospital in Liège. His is trained as anaesthetist and since 1987 he spent most of his time working in the intensive care unit. His involvement in medical ethics and taking care of the critically ill have led him to the domain of providing care to critically ill patient during their end of life phase.

François Damas is the chairman of the ethic committee of his hospital and is a member of the Belgian federal commission on euthanasia, a position that is much controversial. Beside the Nederland and Luxembourg, the Belgian Law on euthanasia is unique in the rest of the world. There is much to learn from the application of such law.

Christian Homsy

Christian Homsy, MD, MBA has been the Chief Executive Officer (CEO) of Cardio3BioSciences since its inception. Cardio3 BioSciences is Belgian leading biopharmaceutical company focused on the discovery, development and commercialization of innovative regenerative, protective and reconstructive therapies for the treatment of cardiac diseases.
Drawing on his medical and business experience in senior research and development, marketing, sales and business development, he aims with his team at bringing to physicians and patients worldwide, the first effective regenerative medicine for the treatment of cardiac diseases.

Grégory « Doc » Van Ass

Greg has been working as a IT consultant for the last 15 years, his customers are large belgian companies. Before that he was already in the IT consulting business working with other technologies. Freelancer since 2004, Greg created a web & mobile agency called iconfrog.
Greg is also a co-founder of the non-profit association GOTORO

Gérome « Marty » Vanherf

Gérôme, alumni @HEC_ULg, works for Cide-Socran in the LeanSquare team, a startups accelerator in Liège. He is also co-founder of @Open_Skills and the non-profit association GOTORO